相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
How does dementia with Lewy bodies start? prodromal cognitive changes in REM sleep behavior disorder
Daphne Genier Marchand et al.
ANNALS OF NEUROLOGY (2018)
TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson's disease
Youwen Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Clinical Subtypes of Dementia with Lewy Bodies Based on the Initial Clinical Presentation
Estrella Morenas-Rodriguez et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders
Susana Carmona et al.
LANCET NEUROLOGY (2018)
The A/T/N biomarker scheme and patterns of brain atrophy assessed in mild cognitive impairment
Urban Ekman et al.
SCIENTIFIC REPORTS (2018)
CSF sAPP beta, YKL-40, and NfL along the ALS-FTD spectrum
Ignacio Illan-Gala et al.
NEUROLOGY (2018)
Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease
Isabel Sala et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer's Disease: A Comparison of the Cognitive and Clinical Profiles
Dilman Sadiq et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer's disease and other tauopathies
Marta Querol-Vilaseca et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Extensive uptake of α-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damage
Veronica Lindstrom et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2017)
YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
Franc Llorens et al.
MOLECULAR NEURODEGENERATION (2017)
Early upregulation of 18-kDa translocator protein in response to acute neurodegenerative damage in TREM2-deficient mice
Sara Belloli et al.
NEUROBIOLOGY OF AGING (2017)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith et al.
NEUROLOGY (2017)
CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration
Daniel Alcolea et al.
NEUROLOGY (2017)
Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease
Babykumari P. Chitramuthu et al.
BRAIN (2017)
Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease
Maria Carmona-Iragui et al.
ALZHEIMERS & DEMENTIA (2017)
Convergent Genetic and Expression Datasets Highlight TREM2 in Parkinson's Disease Susceptibility
Guiyou Liu et al.
MOLECULAR NEUROBIOLOGY (2016)
Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
Laura Piccio et al.
ACTA NEUROPATHOLOGICA (2016)
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers
Marc Suarez-Calvet et al.
EMBO MOLECULAR MEDICINE (2016)
Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis
M. Alba Mane-Martinez et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease
Amanda Heslegrave et al.
MOLECULAR NEURODEGENERATION (2016)
Glia and alpha-synuclein in neurodegeneration: A complex interaction
Dominik Brueck et al.
NEUROBIOLOGY OF DISEASE (2016)
How neuroinflammation contributes to neurodegeneration
Richard M. Ransohoff
SCIENCE (2016)
Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury
Marc Suarez-Calvet et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias
Estrella Morenas-Rodriguez et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
Innate immunity in Alzheimer's disease
Michael T. Heneka et al.
NATURE IMMUNOLOGY (2015)
Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
Daniel Alcolea et al.
NEUROLOGY (2015)
The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies
Malin Wennstrom et al.
PLOS ONE (2015)
Progranulin polymorphism rs5848 is associated with increased risk of Alzheimer's disease
Jinghao Sheng et al.
GENE (2014)
Relationship Between β-Secretase, Inflammation and Core Cerebrospinal Fluid Biomarkers for Alzheimer's Disease
Daniel Alcolea et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Intracellular processing of disease-associated α-synuclein in the human brain suggests prion-like cell-to-cell spread
Gabor G. Kovacs et al.
NEUROBIOLOGY OF DISEASE (2014)
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Gernot Kleinberger et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
The Glial Marker YKL-40 Is Decreased in Synucleinopathies
Bob Olsson et al.
MOVEMENT DISORDERS (2013)
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Thorlakur Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
TREM2 Variants in Alzheimer's Disease
Rita Guerreiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts
Lisa Fellner et al.
ACTA NEUROPATHOLOGICA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
The Early Involvement of the Innate Immunity in the Pathogenesis of Late-onset Alzheimer's Disease: Neuropathological, Epidemiological and Genetic Evidence
P. Eikelenboom et al.
CURRENT ALZHEIMER RESEARCH (2011)
Structure, Function, and Mechanism of Progranulin; the Brain and Beyond
Huishi Toh et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
Rebecca Craig-Schapiro et al.
BIOLOGICAL PSYCHIATRY (2010)
Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies
He-Jin Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members
NiCole Finch et al.
BRAIN (2009)
Homocysteine and Cognitive Impairment Relation with Diagnosis and Neuropsychological Performance
Isabel Sala et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2008)
Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease
N. Brouwers et al.
NEUROLOGY (2008)
Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration
R. Ghidoni et al.
NEUROLOGY (2008)
Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2007)
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Matt Baker et al.
NATURE (2006)
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21
Marc Cruts et al.
NATURE (2006)
Mild cognitive impairment -: beyond controversies, towards a consensus:: report of the International Working Group on Mild Cognitive Impairment
B Winblad et al.
JOURNAL OF INTERNAL MEDICINE (2004)
分享论文
